- Location
limb ischemia
"-
Initiation of TOBA-BTK Study Has Been Declared by Intact Vascular
Dec 19, 2013Intact Vascular, a developer of medical devices for minimally invasive peripheral vascular procedures, has announced the start of enrollment in the Tack Optimized Balloon Angioplasty Below the Knee (TOBA-BTK) study. This multi-center ...
Tags: Intact Vascular, medical devices
-
Cha Bio&Diostech Has Filed Its First Investigational New Drug (IND) Application
Jul 10, 2013Cha Bio&Diostech, a South Korean partner of Pluristem Therapeutics, has filed its first investigational new drug (IND) application for Pluristem’s PLacental eXpanded (PLX) cells with the Korean Food and Drug Administration (KFDA). ...
Tags: PLX Cells, Cha Bio&Diostech
-
Balloon Catheters Are Scored by AngioScore PTA
Jan 29, 2013AngioScore, a US based endovascular company, has launched new 100 mm length AngioSculpt PTA Scoring Balloon Catheters to treat complex lesions in patients with peripheral artery disease (PAD) below the knee (BTK) including critical limb ...
Tags: AngioScore, PTA Scoring Balloon Catheters, peripheral artery disease, PAD
-
Patient Enrollment Is Completed by Medtronic in Amphirion Balloon Trial
Dec 18, 2012Medtronic has completed enrolling patients in a clinical trial of its Amphirion drug-eluting balloon, designed to treat critical limb ischemia. The CE-marked Amphirion drug-eluting balloon features proprietary FreePac proprietary ...
Tags: Medtronic, clinical trial, limb ischemia, Amphirion drug-eluting balloon
-
Final Results of Definitive LE Trial Has Been Reported by Covidien
Dec 18, 2012Covidien has reported final 12-month results from Determination of Effectiveness of SilverHawk / TurboHawk Peripheral Plaque Excision Systems for the Treatment of Infrainguinal Vessels/Lower Extremities (DEFINITIVE LE ) trial. The ...
Tags: Covidien, 12-month results, DEFINITIVE LE trial, prospective study
-
Boston Scientific Launches Victory Guidewire in the US and Europe
Dec 17, 2012Boston Scientific has launched Victory guidewire, designed to provide access to cross and treat resistant lesions in the US and Europe. The company said resistant lesions are characterized by blockage or narrowing of blood vessels in the ...
Tags: Victory guidewire, Boston Scientific, resistant lesions
-
Harvest Has Awarded a CE Mark for Expanded Indication of Bone Marrow Aspiration System
Nov 27, 2012The British Standards Institution (BSI), a notified body under the Medical Device Directive, has awarded a CE mark for the expanded clinical indication for Harvest Technologies' SmartPReP 2 Bone Marrow Aspiration Concentration System (BMAC ...
